223 — Elife Holdings Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -43.12% | ||
| Return on Equity | -26.96% | ||
| Operating Margin | -12.71% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 54.79 | 276.04 | 152.6 | 238.84 | 184.09 | n/a | n/a | 15.55% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Elife Holdings Ltd is an investment holding company principally engaged in supply chain business for branded goods and consumer products. The Company operates business through four segments. The Supply Chain Business segment is engaged in the supply chain business for branded goods and consumer products, assisting brand suppliers expanding sales channels and offering value-added services such as brand building, management and promotion. The Daily Clearing, Anti-epidemic and Other Consumable Products Business segment is engaged in the sales, marketing and brand building of daily cleaning, anti-epidemic and other consumable products. The Licensed Branded Consumer Goods Business segment is engaged in the online sales via television network and online shopping channels of the licensed branded consumer goods. The Esmart Digital Services segment is engaged in provision of esmart digital services.
Directors
- Xiaobin Zhang CHM (64)
- Sui Keung Chiu CEO (49)
- Feng Gao VCH (45)
- Tak Yuen Ho OTH (54)
- Kenneth Sinclair OTH
- Chi Fai Chow SEC (50)
- Wing Keung Cheng NID (56)
- Lee Lam NID (62)
- Williamson Lam NID (43)
- Hoi Kuen Wong NID (59)
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- December 20th, 2001
- Public Since
- April 10th, 2002
- No. of Employees
- 66
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,356,171,754
- Address
- Room 2502
- Web
- https://www.elife.com.hk
- Phone
- +852 null25196668
- Auditors
- HLB Hodgson Impey Cheng
Upcoming Events for 223
Similar to 223
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the Elife Holdings share price?
As of Today at 20:25 UTC, shares in Elife Holdings are trading at HK$0.11. This share price information is delayed by 15 minutes.
How has the Elife Holdings share price performed this year?
Shares in Elife Holdings last closed at HK$0.11 and the price had moved by -52.61% over the past 365 days. In terms of relative price strength the Elife Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -52.07% over the past year.
What are the analyst and broker recommendations for Elife Holdings?
There is no consensus recommendation for this security.
Find out moreWhat is the Elife Holdings dividend yield?
Elife Holdings does not currently pay a dividend.
Does Elife Holdings pay a dividend?
Elife Holdings does not currently pay a dividend.
When does Elife Holdings next pay dividends?
Elife Holdings does not currently pay a dividend.
How do I buy Elife Holdings shares?
To buy shares in Elife Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Elife Holdings?
As of the previous close price of HK$0.11, shares in Elife Holdings had a market capitalisation of .
Where are Elife Holdings shares listed?
Here are the trading details for Elife Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 223
What kind of share is Elife Holdings?
Based on an overall assessment of its quality, value and momentum Elife Holdings is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Elife Holdings share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Elife Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Elife Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -50.85%.
As of the last closing price of HK$0.11, shares in Elife Holdings were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Elife Holdings PE Ratio?
The Elife Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.11.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Elife Holdings?
Elife Holdings' management team is headed by:
- Xiaobin Zhang - CHM
- Sui Keung Chiu - CEO
- Feng Gao - VCH
- Tak Yuen Ho - OTH
- Kenneth Sinclair - OTH
- Chi Fai Chow - SEC
- Wing Keung Cheng - NID
- Lee Lam - NID
- Williamson Lam - NID
- Hoi Kuen Wong - NID